Table 2. Disease extent (n = 57).
| Seminoma (n = 20) | Nonseminoma (n = 37) | |
|---|---|---|
| Median tumour size (in cm) (range) | Median 12.5 (7–23) |
Median 12 (5–20) |
| Nodes involved (%) | ||
| • Mediastinal | 2 (10) | 7 (18.9) |
| • Nonmediastinal | 7 (35) | 5 (13.5) |
| • None | 11 (55) | 25 (67.6%) |
| SVCO present (%) | 8 (40) | 9 (24.3%) |
| Other local complications (%) | ||
| • Pericardial | 6 (30) | 11 (29.7%) |
| • Pleural or lung | 5 (25) | 17 (45.9%) |
| • Vocal cord palsies | 2 (10) | 1 (2.7%) |
| • Others (atrial, rib, spinal cord) | 1 (5) | 9 (24.3%) |
| • None | 9 (45) | 7 (18.9) |
| • Two or more of the above | 3 (15) | 6 (16%) |
| Distant metastases present, outside mediastinum (%) | 2 (10%) | 15 (40%) |
| Sites of distant metastases (osseous, visceral, both, none) | ||
| • Osseous | 1 | 2 (5.4%) |
| • Viscerala | 1 | 8 (21.6%) |
| • None | 0 | 5 (13.5%) |
| • Both osseous and visceral | 0 | 22 (59.5%) |
| Brain metastases present | 0 | 3 (8.1%) |
| HCG ≥ 1,000 | x | 5 (13.5%) |
| IGCCCG risk staging (%) | ||
| • Good risk | 9 (45%) | 0 |
| • Intermediate risk | 11 (55%) | 0 |
| • Poor risk | X | 37 (100%) |
SVCO: superior vena cava obstruction
a
One patient had a 3mm indeterminate lung nodule.